Member

Login to your account, make a payment, see benefits and more.

Members

Manage Your Plan

Helpful Tools

Wellcare By Fidelis Care

Members
Providers

Login to your account, download forms, view auth grids and more.

Providers

Provider Resources

About Our Plans

Helpful Tools

Providers
Shop For a Plan

See plan benefits, coverage areas, get a quote and more.

Shop for a Plan

Our Plans

Helpful Tools

Wellcare By Fidelis Care

Shop for a Plan
AAA
HomeMemberHelpful ToolsHealth ResourcesSocial Determinants of HealthGiving Back

Giving Back to Our Communities

Fidelis Care and the Centene Foundation Award $1.1 Million to The Jed Foundation to Protect the Mental Health of New York’s Youth

Funding will help expand emotional well-being resources, educational workshops, and training programs for community-based organizations that foster communities of care statewide

September 20, 2024, NEW YORK CITY —  Fidelis Care, a leading health insurer providing quality, affordable coverage to New Yorkers, and the Centene Foundation, the philanthropic arm of Centene Corporation, announced today a $1.1 million grant to The Jed Foundation (JED), a national nonprofit that protects emotional health and prevents suicide for teens and young adults.

With this grant, JED will expand its current services, providing at least five youth-serving community-based organizations (CBOs) with consultation or strategic planning services, including expert guidance, educational workshops, and training programs, equipping young people with life skills and connecting them to mental health care when they are in distress.

“We are thrilled to support the vital work of The Jed Foundation with this grant,” said Vincent Marchello, Chief Medical Officer at Fidelis Care. “At Fidelis Care, we recognize the importance of mental health services in creating healthier communities. This investment underscores our commitment to ensuring youth and adolescents have access to the critical support they need to thrive.”

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), it is currently estimated that nearly one in five 12- to 17-year-olds in the United States experience a major depressive episode every year, and almost half of teens 13 to 17 say they would seek out professional help only as a last resort. In New York State, the need for enhanced mental health support for school-aged youth is critical: in 2021, 57% of New York 12- to 17-year-olds with depression had not received any care in the last year.

“JED is grateful to Fidelis Care and the Centene Foundation for their commitment to supporting the emotional well-being of New York youth and for providing the resources to help them thrive,” said John MacPhee, JED Chief Executive Officer. “This partnership will allow us to bring JED’s lifesaving work to community-based organizations across the state and help them build on their mental health safety nets and approaches, while positively impacting the lives of thousands of young people.”

The inaugural group of CBOs includes Bottom Line, an organization that partners with degree-aspiring students from first-generation and low-income backgrounds as they get into and through college and launch mobilizing first careers; Hetrick-Martin Institute, which provides free, year-round programs and services for LGBTQIA+ youth and allies aged 13 to 24 in New York City; and Prep for Prep, which provides first-rate educational, leadership development and professional advancement opportunities for young people of color in New York City.

"Through decades of experience at Bottom Line, we have seen that the condition of a student's mental health plays a significant role in their overall journey to becoming a college graduate and professional,” said Sheneita R. Graham, Director of Culturally Responsive Programming at Bottom Line. “Our role at Bottom Line is to build strong relationships that assist us in determining need and connecting students to resources that will help them thrive personally to persist academically. Partnering with The Jed Foundation grants us the opportunity to expertly assess our mental health policies, processes, and resources to ensure we provide our students with thoughtful, high-quality support."

"Hetrick-Martin Institute is pleased to be working with The Jed Foundation to improve our ability to recognize young people in distress and conduct suicide risk assessments," said Bridget Hughes, Chief Program Officer at Hetrick-Martin Institute.

"We are so grateful to The Jed Foundation for hosting two workshops for our incoming college freshmen as part of our annual College Transition Retreat,” said Corey Rhoades, Director of Undergraduate Affairs at Prep for Prep. “The presenters shared their expertise and tailored the sessions in a way that was uniquely relevant and engaging for our students."

To learn more about ways to provide community-based organizations with consulting, evidence-based best practices, and data-driven guidance to protect youth mental health and prevent suicide, visit JED’s website.

Fidelis-JED-Social

Screener Program Provides Support to Families Impacted by Social Determinants of Health

SDoH-chart

Fidelis Care’s innovative SDoH screener program was launched two years ago as a grassroots health equity initiative to address conditions in the environments where people are born, live, work, and play that affect their health, well-being, and quality of life. Social Determinants of Health can affect a wide range of health risks and outcomes – particularly among vulnerable populations and in underserved areas.

The screener enables trained Fidelis Care representatives to assess an individual’s immediate needs and challenges related to SDoH through a brief series of questions covering areas such as access to transportation, food, and secure and safe housing. More than 450,000 Fidelis Care members have participated to date.


Click here to learn more about the different Social Determinants of Health and find available resources.

More News:


IV Fluid Shortage and Pharmaceutical Prior Authorization Requests
11/12/2024 • Posted by Provider Relations in Provider News

As you may know, the United States is experiencing an IV fluid shortage after Hurricane Helene.  Fidelis Care would like to provide guidance regarding prior authorization (PA) requests that may be affected by this shortage.
 

Medications for use in Non-Oncology Diagnoses (PA Requests Submitted Directly to Fidelis Care Pharmacy)

  • Fidelis Care is aware of the IV Fluid supply chain issues and has processes in place to consider the impacts of the IV Fluid shortages when reviewing medication Prior Authorization (PA) requests, for as long as the shortage is in effect.
  • Providers must include communication and/or documentation that the medication Prior Authorization (PA) request is connected to and/or secondary to the IV Fluid shortage.

 

Medications for use in Oncology Diagnoses (PA Requests Submitted Directly to Evolent Specialty/NCH)

  • Evolent Specialty/NCH is aware of the IV Fluid supply chain issues and has processes in place to consider the impacts of the IV Fluid shortages when reviewing medication Prior Authorization (PA) requests, for as long as the shortage is in effect.
  • Evolent Specialty/NCH will consider the IV Fluid shortage when reviewing medication Prior Authorization (PA) requests for non-preferred medications when providers include notation indicating the request’s connections shortage, for as long as the shortage is in effect.
  • Providers must include communication and/or documentation that the medication Prior Authorization (PA) request is connected to and/or secondary to the IV Fluid shortage.

 

Provider Guidance

  • When submitting medication PA requests connected to and/or secondary to the IV Fluid shortage, providers should clearly indicate that the medication/medication formulation is requested secondary to the IV bag supply chain issues.
  • For any medication PA requests where a provider is requesting a change from an IV medication formulation to a SQ (SC) medication formulation secondary to the IV bag supply chain issues, providers clearly communicate this on their PA submission(s).
    • (E.g.) “Changing product/formulation due to IV fluid shortage.”

 

For additional questions, or if we can be of assistance in any way, please contact your Fidelis Care Provider Engagement Account Manager. To find your designated representative, please visit Contact Your Designated Provider Relations Specialist.

Thank you for being a valued Fidelis Care partner in the provision of quality care.


IV Fluid Shortage and Pharmaceutical Prior Authorization Requests
11/12/2024 • Posted by Provider Relations in Provider News

As you may know, the United States is experiencing an IV fluid shortage after Hurricane Helene.  Fidelis Care would like to provide guidance regarding prior authorization (PA) requests that may be affected by this shortage.
 

Medications for use in Non-Oncology Diagnoses (PA Requests Submitted Directly to Fidelis Care Pharmacy)

  • Fidelis Care is aware of the IV Fluid supply chain issues and has processes in place to consider the impacts of the IV Fluid shortages when reviewing medication Prior Authorization (PA) requests, for as long as the shortage is in effect.
  • Providers must include communication and/or documentation that the medication Prior Authorization (PA) request is connected to and/or secondary to the IV Fluid shortage.

 

Medications for use in Oncology Diagnoses (PA Requests Submitted Directly to Evolent Specialty/NCH)

  • Evolent Specialty/NCH is aware of the IV Fluid supply chain issues and has processes in place to consider the impacts of the IV Fluid shortages when reviewing medication Prior Authorization (PA) requests, for as long as the shortage is in effect.
  • Evolent Specialty/NCH will consider the IV Fluid shortage when reviewing medication Prior Authorization (PA) requests for non-preferred medications when providers include notation indicating the request’s connections shortage, for as long as the shortage is in effect.
  • Providers must include communication and/or documentation that the medication Prior Authorization (PA) request is connected to and/or secondary to the IV Fluid shortage.

 

Provider Guidance

  • When submitting medication PA requests connected to and/or secondary to the IV Fluid shortage, providers should clearly indicate that the medication/medication formulation is requested secondary to the IV bag supply chain issues.
  • For any medication PA requests where a provider is requesting a change from an IV medication formulation to a SQ (SC) medication formulation secondary to the IV bag supply chain issues, providers clearly communicate this on their PA submission(s).
    • (E.g.) “Changing product/formulation due to IV fluid shortage.”

 

For additional questions, or if we can be of assistance in any way, please contact your Fidelis Care Provider Engagement Account Manager. To find your designated representative, please visit Contact Your Designated Provider Relations Specialist.

Thank you for being a valued Fidelis Care partner in the provision of quality care.